Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled trial of inhaled colistin in COPD and/or non-cystic fibrosis bronchiectasis with chronic Pseudomonas aeruginosa bronchial infection
2008-006144-18Phase 3Active
- Sponsor
- Complejo Hospitalario Universitario de Albacete
- Start
- Mar 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute bronchitis, chronic obstructive pulmonary disease (COPD) and bronchiectasis comparing Inhaled colistin with Placebo (2 arms). Primary endpoint: Primary clinical variables at baseline and post-treatment. Started Mar 2009; status: active.
02
Drugs
colistin
03
Conditions
acute bronchitischronic obstructive pulmonary disease (COPD)bronchiectasis
Beyond the preview
Go deeper on 2008-006144-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006144-18.